Zenas Biopharma (ZBIO)Soros Fund Management exited its position 38K shares

38K

Prior-quarter shares · no longer reported

Holdings as of

Dec 31, 2024

Filed

Feb 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 7, 2025InsiderDirector purchased ~$78K of ZBIO shares in the open market

What came next

1. Feb 18, 2025InsiderCEO purchased ~$167K of ZBIO shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Zenas Biopharma

OQRO holds no insider, Congress, fund or contract record for Zenas Biopharma dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZBIO page.

How this filing works

• SEC Form 13F

Other disclosures at Zenas Biopharma

• SEC Form 13F-HRFeb 17, 2026
• SEC Form 4Apr 28, 2025
• SEC Form 4Feb 19, 2025
• SEC Form 13F-HRFeb 14, 2025
• SEC Form 4Dec 5, 2024
• SEC Form 4Dec 5, 2024

Everything OQRO holds on this company is on its ZBIO page.